Utility Therapeutics Ltd. | WebDisclosure

Basculer en Français

10700	Companies
228724	Keywords
157340	Articles
121407	Press releases

Headlines Articles Press releases Utility Therapeutics Ltd.

Home
Companies
Utility Therapeutics Ltd.

PRESS RELEASE

published on 01/17/2024 at 12:00, 2 years 5 months ago

UTILITY therapeutics Ltd. Announces Financing Led by the AMR Action Fund and FDA Acceptance of PIVYA New Drug Application with Priority Review
UTILITY therapeutics Ltd. announces a private financing led by the AMR Action Fund and the U.S. FDA's acceptance of its New Drug Application (NDA) for PIVYA, a European-approved antibiotic for the treatment of uncomplicated urinary tract infections (UTIs). PIVYA has received the FDA's qualified infectious disease product (QIDP) designation, providing an additional 5 years of market exclusivity upon approval. This new antibiotic offers a unique mechanism of action and aims to address the rising rates of antimicrobial resistance. For more information, visit www.utilitytherapeutics.com.

UTILITY Therapeutics PIVYA Urinary Tract Infections Antibiotic FDA Approval

Accesswire

Published on 07/08/2026 at 16:45, 2 hours 17 minutes ago

Change Of Record Date for Special Meeting
Published on 07/08/2026 at 15:25, 3 hours 37 minutes ago

Rockhaven Announces Granting of Incentive Stock Options
Published on 07/08/2026 at 15:00, 4 hours 2 minutes ago

Karbon-X Announces Strategic Partnership to Evaluate Kenya BioHub Initiative
Published on 07/08/2026 at 15:00, 4 hours 2 minutes ago

GameSquare's Stream Hatchet Publishes Esports Live Streaming Trends Report
Published on 07/08/2026 at 14:30, 4 hours 32 minutes ago

Research Analyst Report on NanoViricides Rates Company "Outperform"; Separately, A "Fireside Chat" Interview of the Company's President Dr. Anil Diwan Hosted by Mr. Dave Donlin was Published by StockInvestor Daily

View all ACCESSWIRE

EQS Group

Published on 07/08/2026 at 18:52, 9 minutes ago

namR: PRONONCÉ DE LA LIQUIDATION JUDICIAIRE DE LA SOCIÉTÉ SA NAM.R
Published on 07/08/2026 at 18:45, 16 minutes ago

EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma publishes preliminary Q3 key figures and raises 2026 revenue and earnings guidance
Published on 07/08/2026 at 18:17, 45 minutes ago

Dividend announcement
Published on 07/08/2026 at 18:16, 45 minutes ago

Kaufman & Broad SA: 2026 FIRST HALF RESULTS
Published on 07/08/2026 at 18:16, 45 minutes ago

Kaufman & Broad SA: RESULTATS DU 1ER SEMESTRE 2026

Les Echos

Published on 07/08/2026 at 18:30, 32 minutes ago

Suspension of the liquidity contract
Published on 07/08/2026 at 18:30, 32 minutes ago

Suspension du contrat de liquidité
Published on 07/08/2026 at 18:00, 1 hour 2 minutes ago

464 M€ DE NOUVEAUX FINANCEMENTS POUR SOUTENIR LA CROISSANCE DE FREY
Published on 07/08/2026 at 18:00, 1 hour 2 minutes ago

€464 MILLION OF NEW FINANCING TO SUPPORT FREY'S GROWTH
Published on 07/08/2026 at 17:45, 1 hour 17 minutes ago

Déclaration des droits de vote à fin juin 2026

View all LES ECHOS COMFI WIRE